247 related articles for article (PubMed ID: 27174920)
21. Effect of BIX-01294 on H3K9me2 levels and the imprinted gene Snrpn in mouse embryonic fibroblast cells.
Chen P; Yao JF; Huang RF; Zheng FF; Jiang XH; Chen X; Chen J; Li M; Huang HF; Jiang YP; Huang YF; Yang XY
Biosci Rep; 2015 Aug; 35(5):. PubMed ID: 26285804
[TBL] [Abstract][Full Text] [Related]
22. EHMT2 epigenetically suppresses Wnt signaling and is a potential target in embryonal rhabdomyosarcoma.
Pal A; Leung JY; Ang GCK; Rao VK; Pignata L; Lim HJ; Hebrard M; Chang KT; Lee VK; Guccione E; Taneja R
Elife; 2020 Nov; 9():. PubMed ID: 33252038
[TBL] [Abstract][Full Text] [Related]
23. Radiation-induced H3K9 methylation on E-cadherin promoter mediated by ROS/Snail axis : Role of G9a signaling during lung epithelial-mesenchymal transition.
Nagaraja SS; Subramanian U; Nagarajan D
Toxicol In Vitro; 2021 Feb; 70():105037. PubMed ID: 33148527
[TBL] [Abstract][Full Text] [Related]
24. Abnormal histone H3K9 dimethylation but normal dimethyltransferase EHMT2 expression in cloned sheep embryos.
Fu L; Zhang J; Yan FX; Guan H; An XR; Hou J
Theriogenology; 2012 Dec; 78(9):1929-38. PubMed ID: 23058792
[TBL] [Abstract][Full Text] [Related]
25. The novel prognostic marker, EHMT2, is involved in cell proliferation via HSPD1 regulation in breast cancer.
Kim SK; Kim K; Ryu JW; Ryu TY; Lim JH; Oh JH; Min JK; Jung CR; Hamamoto R; Son MY; Kim DS; Cho HS
Int J Oncol; 2019 Jan; 54(1):65-76. PubMed ID: 30365075
[TBL] [Abstract][Full Text] [Related]
26. Targeting EHMT2/ G9a for cancer therapy: Progress and perspective.
Jan S; Dar MI; Wani R; Sandey J; Mushtaq I; Lateef S; Syed SH
Eur J Pharmacol; 2021 Feb; 893():173827. PubMed ID: 33347828
[TBL] [Abstract][Full Text] [Related]
27. G9a/EHMT2 is a Potential Prognostic Biomarker and Molecular Target in SHH Medulloblastoma.
Souza BK; Freire NH; Jaeger M; de Farias CB; Brunetto AL; Brunetto AT; Roesler R
Neuromolecular Med; 2022 Dec; 24(4):392-398. PubMed ID: 35113321
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Histone Methyltransferase G9a Attenuates Noise-Induced Cochlear Synaptopathy and Hearing Loss.
Xiong H; Long H; Pan S; Lai R; Wang X; Zhu Y; Hill K; Fang Q; Zheng Y; Sha SH
J Assoc Res Otolaryngol; 2019 Jun; 20(3):217-232. PubMed ID: 30710318
[TBL] [Abstract][Full Text] [Related]
29. The lysine methyltransferase Ehmt2/G9a is dispensable for skeletal muscle development and regeneration.
Zhang RH; Judson RN; Liu DY; Kast J; Rossi FM
Skelet Muscle; 2016; 6():22. PubMed ID: 27239264
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic priming by EHMT1/EHMT2 in acute lymphoblastic leukemia induces TP53 and TP73 overexpression and promotes cell death.
Silva-Carvalho AÉ; Alencar APD; Resende MR; da Costa DF; Nonino A; Neves FAR; Saldanha-Araujo F
Toxicol In Vitro; 2020 Dec; 69():104992. PubMed ID: 32889036
[TBL] [Abstract][Full Text] [Related]
31. G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression.
Zhang X; Peng D; Xi Y; Yuan C; Sagum CA; Klein BJ; Tanaka K; Wen H; Kutateladze TG; Li W; Bedford MT; Shi X
Nat Commun; 2016 Mar; 7():10810. PubMed ID: 26960573
[TBL] [Abstract][Full Text] [Related]
32. Expression and prognostic significance of chromatin modulators EHMT2/G9a and KDM2b in acute myeloid leukemia.
Gouda MBY; Zidane MA; Abdelhady AS; Hassan NM
J Cell Biochem; 2022 Aug; 123(8):1340-1355. PubMed ID: 35696556
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Euchromatic Histone Lysine Methyltransferase 2 (EHMT2) Suppresses the Proliferation and Invasion of Cervical Cancer Cells.
Chen G; Yu X; Zhang M; Zheng A; Wang Z; Zuo Y; Liang Q; Jiang D; Chen Y; Zhao L; Jiang L; Li D; Liao S
Cytogenet Genome Res; 2019; 158(4):205-212. PubMed ID: 31434093
[TBL] [Abstract][Full Text] [Related]
34. The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation.
Ding J; Li T; Wang X; Zhao E; Choi JH; Yang L; Zha Y; Dong Z; Huang S; Asara JM; Cui H; Ding HF
Cell Metab; 2013 Dec; 18(6):896-907. PubMed ID: 24315373
[TBL] [Abstract][Full Text] [Related]
35. EHMT2/G9a as an Epigenetic Target in Pediatric and Adult Brain Tumors.
Souza BK; Freire NH; Jaeger M; de Farias CB; Brunetto AL; Brunetto AT; Roesler R
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681949
[TBL] [Abstract][Full Text] [Related]
36. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
[TBL] [Abstract][Full Text] [Related]
37. Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294.
Chang Y; Zhang X; Horton JR; Upadhyay AK; Spannhoff A; Liu J; Snyder JP; Bedford MT; Cheng X
Nat Struct Mol Biol; 2009 Mar; 16(3):312-7. PubMed ID: 19219047
[TBL] [Abstract][Full Text] [Related]
38. G9a promotes cell proliferation and suppresses autophagy in gastric cancer by directly activating mTOR.
Yin C; Ke X; Zhang R; Hou J; Dong Z; Wang F; Zhang K; Zhong X; Yang L; Cui H
FASEB J; 2019 Dec; 33(12):14036-14050. PubMed ID: 31647887
[TBL] [Abstract][Full Text] [Related]
39. Multiple Histone Lysine Methyltransferases Are Required for the Establishment and Maintenance of HIV-1 Latency.
Nguyen K; Das B; Dobrowolski C; Karn J
mBio; 2017 Feb; 8(1):. PubMed ID: 28246360
[TBL] [Abstract][Full Text] [Related]
40. α-Synuclein enhances histone H3 lysine-9 dimethylation and H3K9me2-dependent transcriptional responses.
Sugeno N; Jäckel S; Voigt A; Wassouf Z; Schulze-Hentrich J; Kahle PJ
Sci Rep; 2016 Nov; 6():36328. PubMed ID: 27808254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
